The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo

被引：0
|
作者：
Anthony Tumber
Laura S. Collins
Kamille Dumong Petersen
Annemette Thougaard
Sanne J. Christiansen
Marielle Dejligbjerg
Peter Buhl Jensen
Maxwell Sehested
James W. A. Ritchie
机构：
[1] TopoTarget UK LTD,Finsen Centre
[2] TopoTarget A/S,Diagnostic Centre
[3] Symbion Science Park,undefined
[4] Rigshospitalet,undefined
[5] Rigshospitalet,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Histone deacetylase inhibitors; Drug combinations; Synergy; 5-fluorouracil; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：275 / 283
页数：8
相关论文
共 50 条
  • [41] BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo
    Liu, Shilei
    Li, Fengnan
    Pan, Lijia
    Yang, Ziyi
    Shu, Yijun
    Lv, Wenjie
    Dong, Ping
    Gong, Wei
    CANCER SCIENCE, 2019, 110 (08) : 2493 - 2506
  • [42] Nuclear factor-κB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101
    Duan, Jianming
    Friedman, Jay
    Nottingham, Liesi
    Chen, Zhong
    Ara, Gulshan
    Van Waes, Carter
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (01) : 37 - 50
  • [43] Inhibition of tumor cell growth in vitro and in vivo by the histone deacetylase inhibitor oxamflatin.
    Plumb, JA
    Braidwood, L
    Finn, PW
    Williams, RJ
    Brown, R
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3800S - 3800S
  • [44] A phase 1 pharmacokinetic (PK) and pharmacodynamic (PD) study of the histone deacetylase (HDAC) inhibitor PXD101 in patients (pts) with advanced solid tumours.
    Steele, N
    Vidal, L
    Plumb, J
    Attard, G
    Rasmussen, A
    Buhl-Jensen, P
    Brown, R
    Blagden, S
    Evans, J
    de Bono, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 200S - 200S
  • [45] In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line
    Kjellström, J
    Kjellén, E
    Johnsson, A
    ACTA ONCOLOGICA, 2005, 44 (07) : 687 - 693
  • [46] The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage
    Feng, Rentian
    Oton, Ana
    Mapara, Markus Y.
    Anderson, Guelsuem
    Belani, Chandra
    Lentzsch, Suzanne
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (03) : 385 - 397
  • [47] Growth arrest, apoptosis and potentiation of 5-fluorouracil and Raltitrexed cytotoxic effect induced by histone deacetylase inhibitor SAHA in colorectal cancer cells
    Budillon, A
    Di Gennaro, E
    Pepe, S
    Bruzzese, F
    Romano, G
    Pelagianis, I
    Mascagni, P
    Leoni, F
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S29 - S29
  • [48] Novel Heat Shock Protein 90 Inhibitor NVP-AUY922 Synergizes With the Histone Deacetylase Inhibitor PXD101 in Induction of Death of Anaplastic Thyroid Carcinoma Cells
    Kim, Si Hyoung
    Kang, Jun Goo
    Kim, Chul Sik
    Ihm, Sung-Hee
    Choi, Moon Gi
    Yoo, Hyung Joon
    Lee, Seong Jin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02): : E253 - E261
  • [49] Histone deacetylase inhibitor Belinostat (PXD-101) represses androgen receptor expression and acts synergistically with castration and bicalutamide treatment to inhibit prostate cancer growth hormone refractory models
    Festuccia, C.
    Gravina, G. L.
    Marampon, F.
    Biordi, L. A.
    Ricevuto, E.
    Ficorella, C.
    Tombolini, V.
    EJC SUPPLEMENTS, 2010, 8 (07): : 62 - 63
  • [50] Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model
    Li, Jie
    Hou, Ni
    Faried, Ahmad
    Tsutsumi, Soichi
    Kuwano, Hiroyuki
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (10) : 1900 - 1909
12345